$8.99
4.29% day before yesterday
Nasdaq, Aug 22, 10:01 pm CET
ISIN
US6412881053
Symbol
NPCE

NeuroPace Inc Stock price

$8.99
-0.36 3.85% 1M
-4.53 33.51% 6M
-2.20 19.66% YTD
+1.98 28.25% 1Y
+4.89 119.27% 3Y
-8.01 47.12% 5Y
-8.01 47.12% 10Y
-8.01 47.12% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
+0.37 4.29%

Key metrics

Basic
Market capitalization
$297.4m
Enterprise Value
$290.9m
Net debt
positive
Cash
$66.3m
Shares outstanding
32.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
3.5 | 3.1
EV/Sales
3.5 | 3.0
EV/FCF
negative
P/B
12.3
Financial Health
Equity Ratio
8.5%
Return on Equity
-338.7%
ROCE
-20.2%
ROIC
-
Debt/Equity
2.5
Financials (TTM | estimate)
Revenue
$84.3m | $96.7m
EBITDA
$-17.1m | $-15.9m
EBIT
$-19.3m | $-21.7m
Net Income
$-24.8m | $-27.4m
Free Cash Flow
$-18.1m
Growth (TTM | estimate)
Revenue
22.1% | 21.0%
EBITDA
34.8% | 20.3%
EBIT
27.0% | -0.2%
Net Income
21.3% | -1.1%
Free Cash Flow
-2.6%
Margin (TTM | estimate)
Gross
74.8%
EBITDA
-20.3% | -16.4%
EBIT
-22.9%
Net
-29.4% | -28.4%
Free Cash Flow
-21.5%
More
EPS
$-0.8
FCF per Share
$-0.6
Short interest
5.7%
Employees
209
Rev per Employee
$380.0k
Show more

Is NeuroPace Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

NeuroPace Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a NeuroPace Inc forecast:

13x Buy
93%
1x Hold
7%

Analyst Opinions

14 Analysts have issued a NeuroPace Inc forecast:

Buy
93%
Hold
7%

Financial data from NeuroPace Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
84 84
22% 22%
100%
- Direct Costs 21 21
18% 18%
25%
63 63
23% 23%
75%
- Selling and Administrative Expenses 57 57
2% 2%
68%
- Research and Development Expense 25 25
19% 19%
30%
-17 -17
35% 35%
-20%
- Depreciation and Amortization 2.19 2.19
1,188% 1,188%
3%
EBIT (Operating Income) EBIT -19 -19
27% 27%
-23%
Net Profit -25 -25
21% 21%
-29%

In millions USD.

Don't miss a Thing! We will send you all news about NeuroPace Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

NeuroPace Inc Stock News

Neutral
Seeking Alpha
11 days ago
NeuroPace, Inc. (NASDAQ:NPCE ) Q2 2025 Earnings Conference Call August 12, 2025 4:30 PM ET Company Participants Joel D. Becker - CEO, President & Director Patrick F.
Neutral
GlobeNewsWire
12 days ago
-- Reported record quarterly revenue of $23.5 million in Q2 2025-- -- Increased full-year 2025 revenue guidance to between $94 million and $98 million and gross margin guidance to between 75% and 76%-- -- Remain on track to submit NAUTILUS data to FDA for potential IGE indication expansion in the second half of 2025— --CMS maintains current MS-DRG assignment for RNS System® procedures-- MOUNTAI...
Neutral
GlobeNewsWire
23 days ago
MOUNTAIN VIEW, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical technology company focused on transforming the lives of people living with epilepsy, today issued the following statement in response to the Centers for Medicare & Medicaid Services (CMS) electing not to finalize its proposed reassignment of epilepsy with neurostimulator cases in the FY 2026 Inpat...
More NeuroPace Inc News

Company Profile

NeuroPace, Inc. develops, manufactures and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's product RNS system is designed for the treatment of medically refractory partial epilepsy includes implantable and external products. The company was founded by Robert Fischell, David Fischell, Tim Fischell, Scott Fischell, Rebecca L. Kuhn, Frank M. Fischer and Martha Morrell on November 19, 1997 and is headquartered in Mountain View, CA.

Head office United States
CEO Joel Becker
Employees 209
Founded 1997
Website www.neuropace.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today